Maybe I can take that question.
As part of these expert group meetings that the World Health Organization is organizing weekly—and we're part of that—many of the vaccine manufacturers are actually presenting their data. They're sharing their data publicly. There is willingness to share the information, the results, with each other.
We have also now seen in the news—and details are just starting to come out—that some of the larger manufacturers, including AstraZeneca, for example, that may have access to certain technologies are considering approaches to make them globally available to other countries, and maybe, under a licence, to allow manufacturing in specific countries. That is something that is currently being looked at and is currently in the process of maturing, so I can't really speak to details, but I think we're seeing that there is a global approach to this.